DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Payan, J.-P.
Right arrow Articles by Vincent, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Payan, J.-P.
Right arrow Articles by Vincent, C. M.

Vol. 29, Issue 6, 843-854, June 2001

In Vivo and in Vitro Percutaneous Absorption of [14C]Di-n-Butylphthalate in Rat

Jean-Paul Payan, Jean-Paul Marty, Jean-Paul Fabry, Dominique Beydon, Isabelle Boudry, Elisabeth Ferrari, Francine Canel, Marie-Christine Grandclaude, and Claire Marie Vincent

Institut National de Recherche et de Sécurité (INRS), Vandoeuvre, France (J.-P.P., J.-P.F., D.B., I.B., E.F., F.C., M.-C.G.); and Laboratoire de Dermatologie et de Cosmétologie, Faculté de Pharmacie, Chatenay-Malabry, France (J.-P.M., C.M.V.)

This study evaluated the toxicokinetics of [14C]di-n-butylphthalate ([14C]DBP) after an intravenous administration (1 and 10 mg/kg, in Cremophor) or a topical application (10 µl/cm2; 10 cm2, neat) in haired male Sprague-Dawley rats. Additional in vivo and in vitro percutaneous penetration studies of [14C]DBP were conducted on male and female haired rats and male hairless rats. After intravenous administration, unchanged DBP disappeared rapidly from the plasma, following a two-exponential function (T1/2beta  = 5-7 min). The peak levels of monobutylphthalate (MBP) and its glucuronide conjugate (MBP-Gluc) occurred 1 to 2 and 20 to 30 min after administration, respectively. These metabolites were intensively and rapidly excreted in urine (57% of the dose). However, about 35% of the dose recovered in urine was primarily excreted in bile (mainly as MBP-Gluc) and underwent hepatobiliary recycling. Unchanged DBP was barely detectable in excreta. DBP rapidly penetrated the skin, which constituted a reservoir. The absorption flux determined for 0.5 to 8 and 8 to 48 h of exposure were 43 and 156 µg/cm2/h, respectively. The higher flux may be due to radial diffusion of DBP in the stratum and/or epidermis. The in vivo and in vitro experiments revealed that DBP was intensively metabolized into the skin. In vivo percutaneous absorption flux was very similar in male and female haired rats. In contrast, the percutaneous absorption determined in vivo and in vitro was higher in hairless than in haired male rats. Absorption flux was accurately estimated from urinary excretion rate of MBP or MBP-Gluc.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Toxicol SciHome page
R. A. Clewell, J. J. Kremer, C. C. Williams, J. L. Campbell Jr, M. E. Andersen, and S. J. Borghoff
Tissue Exposures to Free and Glucuronidated Monobutylyphthalate in the Pregnant and Fetal Rat following Exposure to Di-n-butylphthalate: Evaluation with a PBPK Model
Toxicol. Sci., June 1, 2008; 103(2): 241 - 259.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.